v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
CURRENT ASSETS:    
Cash and cash equivalents $ 19,894 $ 16,232
R&D tax credit incentive receivable 709 654
Prepaid expenses and other current assets 1,032 1,012
Total current assets 21,635 17,898
Property and equipment, net 2,850 2,879
Operating lease right-of-use assets, net 16,169 17,230
Restricted cash 892 1,338
Deposits and other assets 93 48
TOTAL ASSETS 41,639 39,393
CURRENT LIABILITIES:    
Accounts payable 1,195 1,032
Accrued expenses 1,629 1,736
Litigation accrual 1,675 1,675
Accrued compensation expense 317 365
Lease liability, current portion 1,843 1,794
Total current liabilities 6,659 6,602
Lease liability, noncurrent portion 16,013 17,061
TOTAL LIABILITIES 22,672 23,663
Commitments and contingencies (Note 12)
STOCKHOLDERS' EQUITY:    
Common stock, par value $0.0001 per share; 300,000 shares authorized; shares issued and outstanding: 89,410 and 76,428 at June 30, 2026 and December 31, 2025, respectively 9 8
Additional paid-in capital 180,609 164,225
Accumulated other comprehensive income 32 30
Accumulated deficit (161,683) (148,533)
TOTAL STOCKHOLDERS' EQUITY 18,967 15,730
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 41,639 $ 39,393